Paradigm Capital Management Inc’s Accretive Health AH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-4,597,100
Closed -$11.2M 183
2016
Q3
$11.2M Buy
4,597,100
+2,555,900
+125% +$6.24M 1.18% 32
2016
Q2
$4.08M Buy
2,041,200
+1,025,600
+101% +$2.05M 0.5% 59
2016
Q1
$2.59M Sell
1,015,600
-225,500
-18% -$575K 0.3% 76
2015
Q4
$3.97M Sell
1,241,100
-304,800
-20% -$975K 0.44% 61
2015
Q3
$3.83M Buy
1,545,900
+15,900
+1% +$39.4K 0.47% 59
2015
Q2
$8.41M Buy
1,530,000
+492,500
+47% +$2.71M 0.87% 36
2015
Q1
$6M Buy
1,037,500
+548,400
+112% +$3.17M 0.62% 49
2014
Q4
$3.35M Buy
489,100
+152,200
+45% +$1.04M 0.33% 82
2014
Q3
$2.61M Buy
336,900
+314,500
+1,404% +$2.44M 0.22% 110
2014
Q2
$175K Buy
+22,400
New +$175K 0.01% 240

Other funds holding AH

Paradigm Capital Management Inc's AH Position: Q4 2016 in Review

Paradigm Capital Management Inc sold out of Accretive Health (AH) in Q4 2016, closing a stake of 4,597,100 shares — an estimated $11.2M sold.

Paradigm Capital Management Inc first reported a position in AH in Q2 2014 and held it in 10 quarters. The position peaked at $11.2M in Q3 2016. 5 funds tracked by Wall St. Rank hold AH as of Q4 2016.

  • Paradigm Capital Management Inc reported no remaining Accretive Health position as of Q4 2016 after selling out during the quarter.
  • Paradigm Capital Management Inc sold 4,597,100 Accretive Health shares in Q4 2016, an estimated $11.2M.
  • Paradigm Capital Management Inc first reported a position in Accretive Health in Q2 2014 and held it in 10 quarters.
  • Paradigm Capital Management Inc's Accretive Health position peaked at $11.2M in Q3 2016.
  • 5 funds tracked by Wall St. Rank held Accretive Health as of Q4 2016.

Based on Paradigm Capital Management Inc's 13F filing for Q4 2016, filed 13 Feb 2017.